Archive: Surveys

3 in 4 surveyed patients show strong interest in replacing medications with both approved and experimental treatments.

Author:
Posted: May 30th, 2024

Over 131 million people in the US — roughly 66% of Americans — take prescription drugs regularly. That’s more than the number of people who watched the Super Bowl this year. And yet, 1 in 3 surveyed patients who take prescription medications said that they were unsatisfied with at least one of their current drugs.

Survey of asthma patients found subgroup with limited acceptance of diagnosis.

Author: parexcel
Posted: September 10th, 2021

In the US today, approximately 20 million adults have asthma. With no cure for asthma, around 8% of Americans use medication to prevent asthma attacks and control symptoms, while pharmaceutical companies quest for new or improved treatments and drug combinations. To better understand patient attitudes toward their breathing problems or asthma diagnosis – along with

International survey shows country with lowest healthcare usage and trust correlates to highest likelihood of clinical trial participation.

Author: parexcel
Posted: June 21st, 2021

Quality care in any healthcare system relies heavily on patients developing and maintaining trust in their healthcare professionals (HCPs). As we’ve witnessed throughout the COVID-19 pandemic, local HCPs informing and guiding patients on proper treatment and preventive measures were more successful than similar messages pushed from government agencies or medical institutions. However, while patient trust

Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available.

Author: parexcel
Posted: April 5th, 2021

Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone.

As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research.

Author: parexcel
Posted: January 5th, 2021

Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent

Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic.

Author: parexcel
Posted: July 21st, 2020

At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most

A growing number of patients are considering clinical trials as the coronavirus pandemic continues.

Author: parexcel
Posted: April 17th, 2020

In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout

Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic.

Author: parexcel
Posted: March 26th, 2020

The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations,

Survey of Huntington’s Disease Patients Indicates Trial Design Should Be More Patient-Centric

Author:
Posted: May 15th, 2019

In a recent survey, Huntington’s Disease patients reported they are more likely to participate in patient-centric clinical trials. Here’s how sponsors and CROs can build more convenient and adaptive studies.

New Survey Highlights Need for Better Patient Engagement in Clinical Trials

Author:
Posted: June 14th, 2017

A new survey indicates that when it comes to patient engagement in clinical research, there’s still a lot of room for improvement.